Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono | Immunology and Biotherapies | Scoop.it
Merck and Novo Nordisk are the latest pharma recruits for the GPCR Consortium, a global nonprofit working to shed light on an underexplored corner of biology and share its discoveries with the public.

Via Dominique Blanchard